• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 在门诊监测患者中的自然病程。

COVID-19's natural course among ambulatory monitored outpatients.

机构信息

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic.

出版信息

Sci Rep. 2021 May 12;11(1):10124. doi: 10.1038/s41598-021-89545-1.

DOI:10.1038/s41598-021-89545-1
PMID:33980931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8115337/
Abstract

Research objective was to detail COVID-19's natural trajectory in relation to the Czech population's viral load. Our prospective detailed daily questionnaire-based telemonitoring study evaluated COVID-19's impact among 105 outpatients. In accordance with government quarantine requirements, outpatients were divided into a cohort with two negative tests at the end of the disease (40 patients) and a cohort with a new algorithm (65 patients) following a 14-day quarantine. Median follow-up differed significantly between the 2 groups (23 days vs. 16 days). Only 6% of patients were asymptomatic during the entire telemonitoring period. Another 13% of patients were diagnosed asymptomatic, as suspected contacts, yet later developed symptoms, while the remaining 81% were diagnosed as symptomatic on average 6 days following symptom onset. Telemonitoring enabled precise symptom status chronicling. The most frequently reported complaints were fevers, respiratory issues, and anosmia. Six patients were eventually hospitalized for complications detected early after routine telemonitoring. During the extended follow-up (median 181 days), anosmia persisted in 26% of patients. 79% of patients in the new quarantine algorithm cohort reported no symptoms on day 11 compared to just 56% of patients in the two negative test cohort upon first testing negative (median-19 days). The highest viral load occurred within 0-2 days of initial symptom onset. Both the PCR viral load and two consecutive PCR negative sample realizations indicated high interindividual variability with a surprisingly fluctuating pattern among 43% of patients. No definitive COVID-19 symptoms or set of symptoms excepting anosmia (59%) and/or ageusia (47%) were identified. No preexisting medical conditions specifically foreshadowed disease trajectory in a given patient. Without a PCR negativity requirement for quarantine cessation, patients could exhibit fewer symptoms. Our study therefore highlights the urgent need for routine ambulatory patient telemedicine monitoring, early complication detection, intensive mass education connecting disease demeanor with subsequent swift diagnostics, and, notably, the need to reevaluate and modify quarantine regulations for better control of SARS-CoV-2 proliferation.

摘要

研究目的是详细描述 COVID-19 与捷克人群病毒载量之间的自然轨迹。我们前瞻性地详细评估了 105 名门诊患者的 COVID-19 影响,每天通过基于问卷的远程监测进行研究。根据政府隔离要求,将门诊患者分为疾病结束时两次检测均为阴性的队列(40 名患者)和新算法队列(65 名患者)。两组患者的中位随访时间差异显著(23 天与 16 天)。在整个远程监测期间,仅有 6%的患者无症状。另有 13%的患者被诊断为无症状,因为他们是疑似接触者,但后来出现了症状,而其余 81%的患者平均在症状出现后 6 天被诊断为症状。远程监测使精确的症状状态记录成为可能。报告最多的症状是发热、呼吸问题和嗅觉丧失。6 名患者最终因常规远程监测后早期发现的并发症住院。在延长的随访期(中位随访期 181 天)中,26%的患者嗅觉丧失持续存在。在新的隔离算法队列中,79%的患者在第 11 天没有症状,而在两次检测均为阴性的队列中,只有 56%的患者在首次检测阴性时(中位-19 天)没有症状。病毒载量最高出现在症状出现后的 0-2 天内。PCR 病毒载量和两次连续的 PCR 阴性样本结果均表明个体间的变异性很高,43%的患者表现出惊人的波动模式。除了嗅觉丧失(59%)和/或味觉丧失(47%)外,没有确定的 COVID-19 症状或症状集。没有任何预先存在的医疗条件能准确预示患者的疾病轨迹。如果不需要 PCR 阴性就停止隔离,患者可能会出现更少的症状。因此,我们的研究强调了常规门诊患者远程医疗监测、早期并发症检测、将疾病表现与随后快速诊断联系起来的密集大众教育以及值得注意的是,需要重新评估和修改隔离规定以更好地控制 SARS-CoV-2 传播的迫切需要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/03c001de1b56/41598_2021_89545_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/9e4ed0ae73b9/41598_2021_89545_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/a66bd473d86a/41598_2021_89545_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/b4c0f3775254/41598_2021_89545_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/abe0d0906258/41598_2021_89545_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/cac9cb10cac7/41598_2021_89545_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/5088d424f4c7/41598_2021_89545_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/03c001de1b56/41598_2021_89545_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/9e4ed0ae73b9/41598_2021_89545_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/a66bd473d86a/41598_2021_89545_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/b4c0f3775254/41598_2021_89545_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/abe0d0906258/41598_2021_89545_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/cac9cb10cac7/41598_2021_89545_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/5088d424f4c7/41598_2021_89545_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b9a/8115337/03c001de1b56/41598_2021_89545_Fig7_HTML.jpg

相似文献

1
COVID-19's natural course among ambulatory monitored outpatients.COVID-19 在门诊监测患者中的自然病程。
Sci Rep. 2021 May 12;11(1):10124. doi: 10.1038/s41598-021-89545-1.
2
Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample.在轻度或中度症状的门诊样本中,COVID-19 的临床特征和病毒载量动态。
PLoS One. 2021 Oct 21;16(10):e0258970. doi: 10.1371/journal.pone.0258970. eCollection 2021.
3
Assessment of Day-7 Postexposure Testing of Asymptomatic Contacts of COVID-19 Patients to Evaluate Early Release from Quarantine - Vermont, May-November 2020.评估 COVID-19 患者无症状接触者在第 7 天的暴露后检测结果,以评估提前解除隔离-佛蒙特州,2020 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2021 Jan 8;70(1):12-13. doi: 10.15585/mmwr.mm7001a3.
4
Use and Cost-Effectiveness of a Telehealth Service at a Centralized COVID-19 Quarantine Center in Taiwan: Cohort Study.台湾集中 COVID-19 检疫中心远程医疗服务的使用和成本效益:队列研究。
J Med Internet Res. 2020 Dec 11;22(12):e22703. doi: 10.2196/22703.
5
SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers.SARS-CoV-2 与无症状和近期有症状的医护人员的高病毒载量有关。
PLoS One. 2021 Mar 18;16(3):e0248347. doi: 10.1371/journal.pone.0248347. eCollection 2021.
6
SARS-CoV-2 Transmission among Marine Recruits during Quarantine.新冠病毒在隔离期间在海军新兵中的传播。
N Engl J Med. 2020 Dec 17;383(25):2407-2416. doi: 10.1056/NEJMoa2029717. Epub 2020 Nov 11.
7
Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic.来自捷克布拉格中央军事医院的第一波新冠疫情数据。
Epidemiol Mikrobiol Imunol. 2020 Winter;69(4):164-171.
8
Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study.390 例 COVID-19 住院和门诊患者嗅觉和味觉减退的患病率:一项横断面研究。
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):691-697. doi: 10.1007/s10096-020-04056-7. Epub 2020 Oct 8.
9
Monitoring and Management of Home-Quarantined Patients With COVID-19 Using a WeChat-Based Telemedicine System: Retrospective Cohort Study.使用基于微信的远程医疗系统对新型冠状病毒肺炎居家隔离患者进行监测与管理:回顾性队列研究
J Med Internet Res. 2020 Jul 2;22(7):e19514. doi: 10.2196/19514.
10
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.隔离一艘游轮上的乘客后,其体内的 SARS-CoV-2 脱落和血清转化:一项病例系列研究。
Lancet Infect Dis. 2020 Sep;20(9):1051-1060. doi: 10.1016/S1473-3099(20)30364-9. Epub 2020 Jun 12.

引用本文的文献

1
Remote Patient Monitoring at Home in Patients With COVID-19: Narrative Review.远程患者监护在 COVID-19 患者家中的应用:叙述性综述。
JMIR Nurs. 2024 Nov 19;7:e44580. doi: 10.2196/44580.
2
Long-term trends in cycle threshold values: a comprehensive analysis of COVID-19 dynamics, viral load, and reproduction number in South Korea.长期循环阈值趋势:韩国 COVID-19 动力学、病毒载量和繁殖数的综合分析。
Front Public Health. 2024 Aug 12;12:1394565. doi: 10.3389/fpubh.2024.1394565. eCollection 2024.
3
Evaluating the impact of COVID-19 on vertigo and hearing impairment: A post-recovery analysis.

本文引用的文献

1
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.基于社区人群的 SARS-CoV-2 感染相关症状和症状群:全州范围的流行病学研究结果。
PLoS One. 2021 Mar 24;16(3):e0241875. doi: 10.1371/journal.pone.0241875. eCollection 2021.
2
COVID-19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste.COVID-19:化学感觉功能障碍的恢复。一项关于嗅觉和味觉的多中心研究。
Laryngoscope. 2021 May;131(5):1095-1100. doi: 10.1002/lary.29383. Epub 2021 Jan 15.
3
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
评估 COVID-19 对眩晕和听力障碍的影响:康复后分析。
Medicine (Baltimore). 2024 Jul 5;103(27):e38819. doi: 10.1097/MD.0000000000038819.
4
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.症状在 COVID-19 诊断模型中的预测作用:纵向观察。
Epidemiol Infect. 2024 Jan 22;152:e37. doi: 10.1017/S0950268824000037.
5
Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020.南非基于人群的病例关联研究估算实验室确诊的 2019 冠状病毒病病例的脱落时间:2020 年 3 月至 12 月。
Pan Afr Med J. 2023 Sep 15;46:24. doi: 10.11604/pamj.2023.46.24.41047. eCollection 2023.
6
A Mixture of Essential Oils from Three Cretan Aromatic Plants Inhibits SARS-CoV-2 Proliferation: A Proof-of-Concept Intervention Study in Ambulatory Patients.三种克里特岛芳香植物精油混合物抑制SARS-CoV-2增殖:一项针对门诊患者的概念验证干预研究。
Diseases. 2023 Aug 9;11(3):105. doi: 10.3390/diseases11030105.
7
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.无症状和出现症状前 SARS-CoV-2 感染的发生和传播潜力:实时系统评价和荟萃分析更新。
PLoS Med. 2022 May 26;19(5):e1003987. doi: 10.1371/journal.pmed.1003987. eCollection 2022 May.
巴瑞替尼联合瑞德西韦治疗住院的新冠成年患者
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
Behavioral measures to fight COVID-19: An 8-country study of perceived usefulness, adherence and their predictors.应对 COVID-19 的行为措施:一项针对 8 个国家的感知有用性、依从性及其预测因素的研究。
PLoS One. 2020 Dec 7;15(12):e0243523. doi: 10.1371/journal.pone.0243523. eCollection 2020.
6
SARS-CoV-2 persistence and non-protective immunity in infected haematological patients.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)在感染血液系统疾病患者中的持续存在及非保护性免疫
Br J Haematol. 2021 Jan;192(2):e51-e54. doi: 10.1111/bjh.17212. Epub 2020 Nov 20.
7
Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.新型冠状病毒肺炎患者严重程度和死亡的预后因素:系统评价。
PLoS One. 2020 Nov 17;15(11):e0241955. doi: 10.1371/journal.pone.0241955. eCollection 2020.
8
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.COVID-19 重症患者早期使用托珠单抗治疗与死亡率的关联。
JAMA Intern Med. 2021 Jan 1;181(1):41-51. doi: 10.1001/jamainternmed.2020.6252.
9
Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.了解严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的病毒脱落:对现有文献的综述。
Infect Control Hosp Epidemiol. 2021 Jun;42(6):659-668. doi: 10.1017/ice.2020.1273. Epub 2020 Oct 20.
10
Outpatient Management of COVID-19: Rapid Evidence Review.COVID-19 门诊管理:快速证据回顾。
Am Fam Physician. 2020 Oct 15;102(8):478-486.